Concepedia

Michael Brilhante

MB

10

Publications

377

Citations

10

H-Index

2017

Active since

Affiliations

University of Bern(Current)

University of Zurich

University Hospital of Zurich

Hirslanden Klinik Aarau

Michael Brilhante is an author at University of Bern specializing in clinical microbiology, drug resistance, and microbiology.

ORCID

Top concepts

Publications per year

2017–2021

10

Publications

10

Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018

Aurélien Nigg, Michael Brilhante, Valentina Dazio et al. · Eurosurveillance · 2019 · 77 citations · Full text

Two decades of blaVIM-2-producing Pseudomonas aeruginosa dissemination: an interplay between mobile genetic elements and successful clones

João Botelho, Filipa Grosso, Sandra Quinteira et al. · Journal of Antimicrobial Chemotherapy · 2017 · 59 citations

Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other multidrug-resistant bacteria in Swiss companion animal clinics

Janne S. Schmidt, Stefan P. Kuster, Aurélien Nigg et al. · Antimicrobial Resistance and Infection Control · 2020 · 52 citations · Full text

Acquisition and carriage of multidrug-resistant organisms in dogs and cats presented to small animal practices and clinics in Switzerland

Valentina Dazio, Aurélien Nigg, Janne S. Schmidt et al. · Journal of Veterinary Internal Medicine · 2021 · 38 citations · Full text

Multidrug resistance and multivirulence plasmids in enterotoxigenic and hybrid Shiga toxin-producing/enterotoxigenic Escherichia coli isolated from diarrheic pigs in Switzerland

Michael Brilhante, Vincent Perreten, Valentina Donà · The Veterinary Journal · 2018 · 32 citations

, , +13

Rows per page

1–5 of 10